The effect of blood in vaginal fluid on the assay of 6-phosphogluconate dehydrogenase has been studied. Alternative assay procedures have been investigated to overcome these effects.
A study of the activity of 6-phosphogluconate dehydrogenase (Enzyme Commission No. 1.1.1.44) in the vaginal fluid of large numbers of women has been carried out to investigate whether the assay of this enzyme would be suitable for widespread application as a screening procedure for early gynaecological cancer (Bonham and Gibbs, 1962; Labrum, 1965; Cameron, 1964; Nerdrum, 1964;  Boyd, Gibbs, Labrum, and Philps, 1967) .
Many specimens of vaginal fluid contain apprecible amounts of blood, although specimens are not taken during menstruation. This is particularly so with specimens from patients with carcinoma of the cervix. During the course of these studies we have observed that blood interferes with the assay used for 6-phosphogluconate dehydrogenase which is based on a final measurement of the extinction at 340 m,u due to NADPH2. Lowry, Passonneau, and Rock (1961) have reported that blood, even at very low concentrations, was capable of greatly accelerating NADH2 and NADPH2 oxidation at pH values from 8 to 12. As the enzyme test described by Bonham and Gibbs (1962) takes place at pH 9 0 considerable reoxidation of the nucleotide may well take place in this test system due to the presence of significant amounts of blood.
This paper deals with the investigation of this problem and describes a method of overcoming it by the addition of tryptophane and nicotinamide to the assay system to inhibit both enzymic and nonenzymic destruction of the nucleotides.
To overcome the difficulty caused by reoxidation of NADPH2 due to the presence of blood, the reduced nucleotide was coupled non-enzymically to cause a reduction of a blue dye (2-6 dichlorophenol indophenol). Thus the reduction can be measured by following the bleaching of the dye at 600 m,u. 
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METHODS
Vaginal fluid was collected from patients with carcinoma of the cervix in the manner described by Bonham and Gibbs (1962) . This source of fluid was chosen to guarantee an active sample. The amount of blood present was determined by the following modification of the method of Meijer (1962) .
Specimens of vaginal fluid were made up to 3 ml. with glass-distilled water and then homogenized using a Teflon pestle in a glass barrel. To 1 ml. of the homogenate 0 15 ml. of 0,14 M ammonia solution was added and the volume made up to 3 ml. After standing for 10 minutes, the sample was centrifuged and the extinctions read at 580, 605, and 630 m,u.
Whole blood (obtained by venepuncture) from the same patient, 0-02 ml. plus 0 15 ml. of 0-14 M ammonia solution, was made up to 3 ml. with glass-distilled water and the extinctions were read at 580 and 605 mit.
The percentage blood in the specimens was calculated as follows: % blood in specimen = (Es8o -E605) -(E605 -E630) sample x 2 (E5E0 -E*05) whole blood
The values were expressed as a percentage of whole blood on the basis of a normal haematocrit value. Blood determinations were performed on the vaginal fluids of 50 patients and were found to fall within the range 0 to 0 5 %.
When investigating the effect of blood on 6-phosphogluconate dehydrogenase activity, samples of vaginal fluid having no significant blood content were taken and the supernatant was prepared as previously described. Aliquots of whole blood obtained by venepuncture using lithium heparin as anticoagulant (lithium heparin was found to have no effect on the enzyme activity) were added to the supematant and made up to a standard final volume with glass-distilled water. Controls were prepared using supematant and water only. Similar aliquots of blood were taken with glass-distilled water to ascertain the enzyme activity contributed by the blood alone.
The assay of 6-phosphogluconate dehydrogenase activity, based on the original assay of Bonham and Gibbs (1962) , was as follows: D. F. Gibbs System I 1-50 ml. glycyl glycine buffer 0-25 M pH 9 0 0 50 ml. 6-phosphogluconate Mg. (6PG) 0-02 M 0*50 ml. nicotinimide-adenine dinucleotide phosphate (NADP) 2 mg./ml. 0 50 ml. supernatant Total 3 00 ml. Blanks 0 50 ml. water instead of 6PG, otherwise as for test.
The reaction was started by the addition of the NADP to the system. The optical density change at 340 mu was recorded over the first five minutes at 25°C.
Experiments using vaginal fluid with increasing blood concentrations showed that at very low blood levels the measured enzyme activity was slightly higher than in the absence of blood and then a rapid fall in measured activity was shown with increasing blood concentration (Fig. 1) .
To overcome this difficulty the reduced nucleotide was coupled with 2-6 dichlorophenol indophenol in the presence of phenazonium methosulphate and the change in optical density was followed at 600 m,u.
System II 1-20 ml. glycyl glycine buffer 0-25 M pH 9 0 0 50 ml. 6 PG Mg. 0-02 M 0 50 ml. NADP 2 mg./ml. 0 05 ml. phenazonium methosulphate 2 mg./ml. 0-25 ml. dichlorophenol indophenol 2 mg./10 ml. 0 50 ml. supernatant Total 3-00 ml. Blanks 0 50 ml. water instead of 6 PG, otherwise as for test.
The reaction was started as before, but the optical density change was measured at 600 mju over the first three minutes at 25°C. In both systems the enzyme values in the presence of blood were the total activity corrected for the activity of blood alone. The units of activity were all expressed ENZYMEI % BLOOD as International Units x 10-2 as described in the International Union of Biochemistry Report of the Commission on Enzymes (1961) . The relationship between the optical density readings obtained from the two systems was calculated from the following formula:-1 I mole NADPH2 produced = fall of OD6oomg of 0-5395/min./3 ml. All assays were performed using a Unicam SP 800 double-beam recording spectrophotometer and the reagents were all supplied by Griffin and George Ltd.
RESULTS
Under the system II assay conditions the initial activation at low blood concentration was hardly apparent and the inhibition at the higher blood concentration was much less marked (Fig. 1) .
It was felt that the apparent inhibition might in some part be due to the presence of nucleotidases.
The effect of adding nicotinamide and tryptophane to the assay system to overcome this problem was investigated (Fig. 2) . Both the nicotinamide and the tryptophane were added dissolved in the NADP solution.
Initially the final nicotinamide concentration was 6-6 x 10-2 M. (25 mg./3 ml. assay system) whilst the final concentration of tryptophane was 8-2 x 10-4 M. (0-5 mg./3 ml. assay system). It was, however, noted that in all experiments, at zero and very low blood concentrations, the measured activity was greater without the nicotinamide and tryptophane. As it had been reported that nicotinamide in high concentration is inhibitory to 6-phosphogluconate dehydrogenase (Dickens and Glock, 1952) , experiments were performed to determine the optimum concentration (Fig. 3) . The result clearly indicated that the optimum concentration of nicotinamide was 2-7 x 10-2 M. (10 mg/3 ml assay system) and when the previous experiments on the effect of blood were repeated using this concentration of nicotinamide, no inhibition of the 6-phosphogluconate dehydrogenase was found and a linear response unaffected by blood concentration with tlhe range of 0 to 0 5 % was demonstrated (Fig. 4) .
CONCLUSIONS
It is clear that blood, even in very lowconcentrations, interferes with the assay of 6-phosphogluconate dehydrogenase, usually giving markedly lower results with the conventional assay method as described in system I. At the 1 % level of blood up to 50% inhibition has been noted (Fig. 1) .
Considerable improvement of the assay is obtained by coupling the reduced NADP to 2-6 dichlorophenol indophenol with phenazine methosulphate. The improvement may be due in part to the diminished oxidation of NADPH2by atmospheric oxygen mediated by the haemoglobin present, but this assay system may be beneficial even in the absence of blood, for vaginal fluid specimens often have an oxidative activity with respect to the 6-phosphogluconate'dehydrogenase system. Certainly much of the apparent inhibition is caused by the nucleotidases present in the blood breaking down the NADPH2 at pH 9 0. This has been overcome by the addition of 10 mg nicotinamide and 0 5 mg tryptophane to the 3 ml. assay system giving a linear response unaffected by blood concentration within the range studied.
In view of widespread study of 6-phosphogluconate dehydrogenase as an enzyme screening procedure for cervical cancer, it is important to realize that contamination of the specimen by blood may be of critical importance. The modifications suggested here show that the inhibiting action of blood can be overcome by the inclusion of nicotinamide and tryptophane. A further improvement in the method has been obtained by the use of 2:6 dichlophenol indolephenol and phenazine methosulphate. 
